Nektar Therapeutics (NASDAQ:NKTR)

23.13
Delayed Data
As of Feb 14
 +0.28 / +1.23%
Today’s Change
15.64
Today|||52-Week Range
44.06
+7.16%
Year-to-Date
No recent news for Nektar Therapeutics.

Today’s Trading

Previous close22.85
Today’s open22.97
Day’s range22.47 - 23.60
Volume2,165,543
Average volume (3 months)2,592,969
Market cap$4.1B
Data as of 4:00pm ET, 02/14/2020

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-166.64%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+287.81%
P/E ratioNM
Price/Sales4.96
Price/Book2.34

Competitors

 Today’s
change
Today’s
% change
ARWRArrowhead Pharmaceut...+0.22+0.54%
MORMorphoSys AG-0.72-2.29%
IMMUImmunomedics Inc-0.40-2.13%
----
Data as of 4:00pm ET, 02/14/2020

Financials

Next reporting dateFebruary 25, 2020
EPS forecast (this quarter)-$0.68
Annual revenue (last year)$1.2B
Annual profit (last year)$681.3M
Net profit margin57.09%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
San Francisco, California

Forecasts